8-K
Current Report
Allarity Therapeutics, Inc. Filed Acc 0001213900-22-038536
Executive or director change · Bylaws or fiscal year change
- Item 5.02 Departure or appointment of directors or officers
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading ea162649-8k_allarity.htm…